BHS Webinar supported by GSK
Navigating Innovations in Multiple Myeloma Treatment at First Relapse
Program:
20:00 – 20:15: Setting the scene: Reconciling the EHA-EMN guidelines with the Belgian landscape at first relapse – Dr. Rutger Callens, AZ Delta
20:15 – 20:30: Making it practical: efficacy, safety, and eligibility considerations for BCMA options versus standard of care at first relapse – Dr. Ornella Rizzo, Institut Jules Bordet
20:30 – 20:45: Planning ahead: potential strategies for further treatment in case of relapse on a BCMA option - Michel Delforge, UZ Leuven
20:45 – 21:00: Q&A/discussion – moderated by Dr. Marie Vercruyssen, Institut Jules Bordet